Can primaquine therapy for vivax malaria be improved?
The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...
Main Authors: | Baird, J, Rieckmann, K |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2003
|
פריטים דומים
-
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
מאת: Baird, J
יצא לאור: (2018) -
Primaquine as anti-relapse therapy for Plasmodium vivax
מאת: Baird, J
יצא לאור: (1998) -
Primaquine therapy for malaria.
מאת: Baird, J, et al.
יצא לאור: (2004) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
מאת: Krudsood, S, et al.
יצא לאור: (2008) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
מאת: Luzzi, G, et al.
יצא לאור: (1992)